AKT1 and metabolic disease: Proteomic analysis revealed that PI3K and AKT expression in the femoral tissue of the model group was significantly reduced, accompanied by exacerbated pathological damage to the femoral tissue, indicating the involvement of the PI3K/AKT pathway in bone loss in rats with PMOP through its association with inflammation and metabolic disorders [28, 29].